HomeCare February 22, 2024
To utilize the feature, users will be able to simply track their sleep twice for more than four hours within a ten-day period
RIDGEFIELD PARK, New Jersey—Samsung Electronics Co., Ltd. announced that the sleep apnea feature1 on the Samsung Health Monitor app2 has received De Novo authorization from the United States Food and Drug Administration (FDA). This feature, which will detect signs of sleep apnea using a compatible Samsung Galaxy watch and phone, is the first of its kind to be authorized by FDA following previous approval by South Korea’s Ministry of Food and Drug Safety (MFDS), announced last October in South Korea.
The sleep apnea feature will enable users over the age of 22 who have not been diagnosed...
Today's Sponsors
Today's Sponsor